Using Metformin to Improve Live Birth Rates in Women with Prediabetes Undergoing IVF
Official title: Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial
Run by Shandong University · NCT06064669 · Data updated 2026-11-12
This study is testing if taking metformin before IVF can help women with prediabetes have a healthier chance of getting pregnant and having a baby.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | Women only |
| Enrollment | 988 (estimated) |
| Sponsor | Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | February 22, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | May 29, 2024 |
| Trial ID | NCT06064669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 20-40 with a diagnosis of prediabetes who plan to undergo a new cycle of IVF, ICSI, or PGT-A.
✕Probably not a fit
Patients diagnosed with diabetes or those taking medications that interfere with glucose metabolism will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy and safety of metformin pretreatment on reproductive outcomes in infertile women diagnosed with prediabetes. It aims to determine whether starting metformin before ovarian stimulation or before frozen embryo transfer can enhance the chances of achieving a healthy live birth compared to a placebo. The study involves administering metformin or placebo to participants and monitoring their reproductive outcomes during in-vitro fertilization procedures.
Why it matters
Potential benefit: If successful, this could significantly increase the likelihood of healthy live births for women with prediabetes undergoing IVF.
How similar studies have gone: Other studies have shown promising results with metformin in improving reproductive outcomes, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women who are diagnosed with prediabetes by ADA criteria, including either IFG, IGT, or HbA1C 5.7-6.4%. 2. Women aged 20-40 years. 3. Women who plan to undergo a new cycle of IVF, ICSI, or PGT-A. Exclusion Criteria: 1. Women who are diagnosed with diabetes according to the ADA criteria11,12, which is meeting one of the following criteria: fasting plasma glucose ≥7.0mmol/L, 2-h plasma glucose during 75-g OGTT ≥11.1mmol/L, HbA1c≥6.5%, or a random plasma glucose≥11.1mmol/L. 2. Women who are taking medicine that interfere with glucose metabolism, such as metformin, oral anti-diabetic agents (sulfonylureas, glinides, thiazolidinediones, α-glycosidase inhibitors, GLP-1 receptor agonist, etc.), weight loss drugs (i.e.orlistat, etc.), glucocorticoids, and growth hormones within 2 months before enrollment. 3. Women with un-corrected hyperthyroidism or hypothyroidism. 4. Women with congenital or acquired abnormal uterine cavity including septate uterus, unicornous uterus, uterus duplex, and intrauterine adhesions. 5. Women with a diagnosis of adenomyosis. 6. Women with untreated hydrosalpinx. 7. Women who plan to undergo PGT-SR or PGT-M. 8. Women with major medical comorbidities, such as known liver disease, known renal disease, or known significant anemia.
Where it's running
-
Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Principal investigator: Zi-Jiang Chen, Professor — Shandong University
- Study coordinator: Zi-Jiang Chen, Professor
- Email: chenzijiang@vip.163.com
- Phone: +0086 531 85651190
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Beetroot juice to boost blood vessels, insulin sensitivity, and exercise in prediabetes on vs. off metformin
In people with prediabetes, this study tests whether short-term inorganic nitrate from beetroot juice can improve blood vessel health, insulin sensitivity, and exercise capacity, and compares those already taking metformin with those who are not.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Hourly stair-climbing snacks to improve blood sugar and heart health in adults with prediabetes
This study tests whether short stair-climbing bursts every hour can improve blood sugar and vascular health in adults with prediabetes.
-
Smart probiotic and nutraceutical approach for cardiometabolic health in older adults
This trial tests whether a probiotic-containing nutraceutical strategy can improve metabolic health and blood pressure in adults over 65 with prediabetes or cardiovascular disease.
-
Family-based diabetes prevention for parents and kids
A family-focused program tests whether a 12-week lifestyle plan can help parents at risk for diabetes lose weight and improve healthy habits for themselves and their children aged 12–17.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.